Skip to search formSkip to main contentSkip to account menu

CASC2 gene

Known as: CANCER SUSCEPTIBILITY CANDIDATE 2, CASC2, cancer susceptibility candidate 2 (non-protein coding) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pancreatic cancer is one of the most fatal malignancies with high mortality. Gemcitabine (GEM)‐based chemotherapy is the most… 
Highly Cited
2018
Highly Cited
2018
Long non‐coding RNA cancer susceptibility candidate 2 (CASC2) is a novel lncRNA and has been indicated as playing tumour… 
2018
2018
2018
2018
The long non‐coding RNA segment cancer susceptibility candidate 2 (CASC2) has been shown to suppress tumor growth in a variety of… 
Highly Cited
2017
Highly Cited
2017
Long noncoding RNAs cancer susceptibility candidate 2 (CASC2) have been demonstrated as playing crucial regulatory roles in a few… 
2017
2017
OBJECTIVE Recently, long non-coding RNAs (lncRNAs) have caught more attention for their role in tumor progression. Lung… 
Highly Cited
2016
Highly Cited
2016
Long non-coding RNAs (lncRNAs) have been shown to play important roles in tumorigenesis. However, the biological functions and… 
Highly Cited
2016
Highly Cited
2016
Recently, long noncoding RNAs (lncRNAs) have been shown to have important regulatory roles in human cancer biology. The aim of…